NEW YORK (GenomeWeb News) - New England Biolabs has licensed Integrated Genomics' ERGO software for gene annotation, metabolic reconstruction, enzyme data mining and comparative genomics research, IG said yesterday.
IG said the ERGO platform integrates data from various types of studies, including genomics, biochemistry, gene expression studies, genetics and literature.
The company said ERGO contains more than 1,180 genomes at “various stages of completion," as well as a network of cellular pathways.
New England Biolabs is a private company that offers recombinant and native enzymes for DNA analysis, genomics, and proteomics.
Financial terms of the agreement were not released.